Positron Emission Tomography (PET) Oncologic Applications - (Effective Date - 2026-10-15) 6.01.29
Effective October 15, 2026, PET imaging for oncologic conditions is medically necessary when the cancer-specific criteria for that diagnosis are met. FDG PET/CT is medically appropriate in a small subset of patients with a high likelihood of cancer when conventional studies are non-diagnostic and the scan is used to determine the optimal site for biopsy. The June 18, 2026 review updated criteria for colorectal and small bowel, esophageal and GE junction, prostate, and other cancers.